Literature DB >> 2185033

The interaction of actin with dystrophin.

B A Levine1, A J Moir, V B Patchell, S V Perry.   

Abstract

Proton NMR spectroscopy of synthetic peptides corresponding to defined regions of human dystrophin has been employed to study the interaction with F-actin. No evidence of interaction with a C-terminal region corresponding to amino acid residues 3429-3440 was obtained. F-actin restricted the mobility of residues 19-27 in a synthetic peptide corresponding to residues 10-32. This suggests that this is a site of F-actin interaction in the intact dystrophin molecule. Identical sequences to that of residues 19-22 in dystrophin, namely Lys-Thr-Phe-Thr are also present in the N-terminal regions of the alpha-actinins implying this is also a site of F-actin interaction with alpha-actinin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2185033     DOI: 10.1016/0014-5793(90)80728-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  32 in total

1.  Disease-causing missense mutations in actin binding domain 1 of dystrophin induce thermodynamic instability and protein aggregation.

Authors:  Davin M Henderson; Ann Lee; James M Ervasti
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

Review 2.  Recent advances in understanding muscular dystrophy.

Authors:  K M Bushby
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

3.  NMR structure of the calponin homology domain of human IQGAP1 and its implications for the actin recognition mode.

Authors:  Ryo Umemoto; Noritaka Nishida; Shinji Ogino; Ichio Shimada
Journal:  J Biomol NMR       Date:  2010-07-20       Impact factor: 2.835

4.  Dystrophin isoform induction in vivo by antisense-mediated alternative splicing.

Authors:  Sue Fletcher; Abbie M Adams; Russell D Johnsen; Kane Greer; Hong M Moulton; Steve D Wilton
Journal:  Mol Ther       Date:  2010-03-23       Impact factor: 11.454

5.  Alternative splicing of dystrophin exon 4 in normal human muscle.

Authors:  S Torelli; F Muntoni
Journal:  Hum Genet       Date:  1996-04       Impact factor: 4.132

6.  A limb-girdle muscular dystrophy 2I model of muscular dystrophy identifies corrective drug compounds for dystroglycanopathies.

Authors:  Peter R Serafini; Michael J Feyder; Rylie M Hightower; Daniela Garcia-Perez; Natássia M Vieira; Angela Lek; Devin E Gibbs; Omar Moukha-Chafiq; Corinne E Augelli-Szafran; Genri Kawahara; Jeffrey J Widrick; Louis M Kunkel; Matthew S Alexander
Journal:  JCI Insight       Date:  2018-09-20

7.  Differential distribution of dystrophin and beta-spectrin at the sarcolemma of fast twitch skeletal muscle fibers.

Authors:  M W Williams; R J Bloch
Journal:  J Muscle Res Cell Motil       Date:  1999-05       Impact factor: 2.698

8.  Opening of tandem calponin homology domains regulates their affinity for F-actin.

Authors:  Vitold E Galkin; Albina Orlova; Anita Salmazo; Kristina Djinovic-Carugo; Edward H Egelman
Journal:  Nat Struct Mol Biol       Date:  2010-04-11       Impact factor: 15.369

9.  Crystal structure of the actin-binding domain of alpha-actinin-4 Lys255Glu mutant implicated in focal segmental glomerulosclerosis.

Authors:  Sung Haeng Lee; Astrid Weins; David B Hayes; Martin R Pollak; Roberto Dominguez
Journal:  J Mol Biol       Date:  2007-12-04       Impact factor: 5.469

10.  Dystrophin is phosphorylated by endogenous protein kinases.

Authors:  M Luise; C Presotto; L Senter; R Betto; S Ceoldo; S Furlan; S Salvatori; R A Sabbadini; G Salviati
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.